|Articles|December 1, 2015
- Applied Clinical Trials-05-01-2013
- Volume 22
- Issue 5
Applied Clinical Trials Digital Edition - May 2013
Subject Recruitment: The Ideas Initiative Trial Design: Early Phase CNS Drug Liabilities; Improving Enrollment Forecasts Also in this issue: Update on Europe's Clinical Trial Rules Debate Public Perception of Clinical Research Clinical Trial Barriers
Advertisement
Articles in this issue
about 13 years ago
The IDEAS Initiativeabout 13 years ago
Sponsors and Service Providers Share Their Experiencesabout 13 years ago
Optimizing Efficiencyabout 13 years ago
Principal Investigators Take the Lead FDA-Regulated Studiesabout 13 years ago
Improving Clinical Trial Enrollment Forecasts Using SORMabout 13 years ago
Breaking Down Clinical Barriersabout 13 years ago
ACT Coverabout 13 years ago
CNS Drug Liabilities in Early Phase Clinical TrialsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5